Invention Grant
- Patent Title: Compounds for the inhibition of indoleamine-2,3-dioxygenase
-
Application No.: US14845428Application Date: 2015-09-04
-
Publication No.: US09771370B2Publication Date: 2017-09-26
- Inventor: Brian A. Sherer
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: EMD Serono Research and Development Institute
- Agent Dwight D. Kim
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D471/12 ; A61K31/4188 ; A61K31/437 ; A61K31/454 ; A61K31/4545 ; A61K31/519 ; A61K45/06 ; C07D471/14 ; C07D487/14
Abstract:
The present invention relates to compounds, and pharmaceutically acceptable compositions thereof, useful as antagonists of IDO, and for the treatment of IDO-related disorders.
Public/Granted literature
- US20160075711A1 COMPOUNDS FOR THE INHIBITION OF INDOLEAMINE-2,3-DIOXYGENASE Public/Granted day:2016-03-17
Information query
